Skip to main content

Table 4 Estimated percentage time in target, diabetes distress and between-group differences for intervention and control groups (secondary analyses)

From: Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial

 

Estimated mean % time in target (95% CI)

Unadjusted

Adjusted*

 

Intervention group (n=)

Control group (n=)

Intervention vs. Control between-group differences (95% CI)

P Value

Intervention vs. Control between-group differences (95% CI)

P Value

Percentage time in target (%)

      

Baseline

      

12 months

      
 

Estimated mean diabetes distress (95% CI)

Unadjusted

Adjusted*

 

Intervention group (n=)

Control group (n=)

Intervention vs. Control between-group differences (95% CI)

P Value

Intervention vs. Control between-group differences (95% CI)

P Value

Diabetes-specific distress (PAID)

      

Baseline

      

12 months

      
  1. *Adjusted by age and IRSD